Effect of vernolide-A, a sesquiterpene lactone from Vernonia cinerea L., on cell-mediated immune response in B16F-10 metastatic melanoma-bearing mice

Immunopharmacology and Immunotoxicology

Volumn 33, Issue 3, 2011, Pages 533-538

  Pratheeshkumar, P ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

antibody dependent cellular cytotoxicity; antibody dependent complement mediated cytotoxicity; cell mediated immunity; natural killer cells; Vernolide A

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; SESQUITERPENE LACTONE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERNOLIDE A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELLULAR IMMUNITY; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; IMMUNE RESPONSE; MALE; MELANOMA; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VERNONIA; VERNONIA CINEREA;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELL LINE, TRANSFORMED; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; SESQUITERPENES; VERNONIA;

ANIMALIA; MUS; VERNONIA CINEREA;

EID: 79961147781     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2010.547501     Document Type: Article

References (43)

1. Fidler, I.J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990, 50, 6130-6138. (Pubitemid 20323663)
2. Manesh, C., Kuttan, G. Efect of naturally occurring isothiocyanates on the immune system. Immunopharmacol. Immunotoxicol. 2003, 25, 451-459. (Pubitemid 37204454)
3. Burleson, G.R., Burleson, F.G., Dietert, R.R. Te cytotoxic T lymphocyte assay for evaluating cell-mediated immune function. Methods Mol. Biol. 2010, 598, 195-205.
4. Tsavaris, N., Kosmas, C., Vadiaka, M., Kanelopoulos, P., Boulamatsis, D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br. J. Cancer 2002, 87, 21-27.
5. Feghali, C., Wright, T. Cytokines in acute and chronic infammation. Front. Biosci. 1997, 2.
6. Arend, W.P., Gabay, C. Cytokines in the rheumatic diseases. Rheum. Dis. Clin. North Am. 2004, 30, 41-67, v. (Pubitemid 38234768)
7. Moretta, L., Bottino, C., Cantoni, C., Mingari, M.C., Moretta, A. Human natural killer cell function and receptors. Curr. Opin. Pharmacol. 2001, 1, 387-391. (Pubitemid 33585988)
8. Claus, M., Watzl, C. Evaluation of human natural killer cell activities in whole blood. Curr. Protoc. Immunol. 2010, Chapter 7, Unit7 39.
9. Vivier, E., Tomasello, E., Baratin, M., Walzer, T., Ugolini, S. Functions of natural killer cells. Nat. Immunol. 2008, 9, 503-510. (Pubitemid 351560519)
10. Barkas, T., AL-Khateeb, S.F., Irvine, W.J., Davidson, N.M., Roscoe, P. Inhibition of antibody-dependent cell-mediated cytotoxicity (ADCC) as a means of detection of immune complexes in the sera of patients with thyroid disorders and bronchogenic carcinoma. Clin. Exp. Immunol. 1976, 25, 270-279.
11. Timonen, T. Natural killer cells: endothelial interactions, migration, and target cell recognition. J. Leukoc. Biol. 1997, 62, 693-701. (Pubitemid 28015616)
12. Newman, D.J., Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461-477. (Pubitemid 46595760)
13. Zhang, S., Won, Y.K., Ong, C.N., Shen, H.M. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr. Med. Chem. Anticancer. Agents 2005, 5, 239-249. (Pubitemid 40645593)
14. Kumar, P.P., Kuttan, G. Vernonia cinerea L. scavenges free radicals and regulates nitric oxide and proinfammatory cytokines profle in carrageenan induced paw edema model. Immunopharmacol. Immunotoxicol. 2009, 31, 94-102.
15. Pratheeshkumar, P., Kuttan, G. Modulation of immune response by Vernonia cinerea L. inhibits the proinfammatory cytokine profle, iNOS, and COX-2 expression in LPS-stimulated macrophages. Immunopharmacol. Immunotoxicol. 2010, 2010 Apr 6. [Epub ahead of print].
16. Pratheeshkumar, P., Kuttan, G. Ameliorative action of Vernonia cinerea L. on cyclophosphamide-induced immunosuppression and oxidative stress in mice. Infammopharmacology 2010, 18, 197-207.
17. Pratheeshkumar, P., Kuttan, G. Protective role of Vernonia cinerea L. against gamma radiation-induced immunosupression and oxidative stress in mice. Hum. Exp. Toxicol. 2010.
18. Kuo, Y.H., Kuo, Y.J., Yu, A.S., Wu, M.D., Ong, C.W., Yang Kuo, L.M., Huang, J.T., Chen, C.F., Li, S.Y. Two novel sesquiterpene lactones, cytotoxic vernolide-A and-B, from Vernonia cinerea. Chem. Pharm. Bull. 2003, 51, 425-426.
19. Chea, A., Hout, S., Long, C., Marcourt, L., Faure, R., Azas, N., Elias, R. Antimalarial activity of sesquiterpene lactones from Vernonia cinerea. Chem. Pharm. Bull. 2006, 54, 1437-1439. (Pubitemid 44506579)
20. Chen, X., Zhan, Z.J., Yue, J.M. Sesquiterpenoids from Vernonia cinerea. Nat. Prod. Res. 2006, 20, 31-35. (Pubitemid 41823596)
21. Kim, Y.B., Huh, N.D., Koren, H.S., Amos, D.B. Natural killing (NK) and antibody-dependent cellular cytotoxicity (ADCC) in specifc pathogen-free (SPF) miniature swine and germfree piglets. I. Comparison of NK and ADCC. J. Immunol. 1980, 125, 755-762. (Pubitemid 10045656)
22. Gupta, S., Bhattacharya, B. Cytotoxicity assays. In: A Handbook of Practical and Clinical Immunology. 2002, Cbs Publishers & Distributor, Delhi, Vol. 1, pp. 299-300.
23. Mitchell, M.S. Immunotherapy as part of combinations for the treatment of cancer. Int. Immunopharmacol. 2003, 3, 1051-1059. (Pubitemid 36830850)
24. Ehrke, M.J. Immunomodulation in cancer therapeutics. Int. Immunopharmacol. 2003, 3, 1105-1119. (Pubitemid 36830855)
25. Fidler, I.J. Immunomodulation of macrophages for cancer and antiviral therapy, in Tomlinson, E and Davis, SS (eds): Site Specifc Drug Delivery. New York, NY, Wiley, 1986, 111-134.
26. Manu, K.A., Kuttan, G. Boerhaavia difusa stimulates cell-mediated immune response by upregulating IL-2 and downregulating the pro-infammatory cytokines and GM-CSF in B16F-10 metastatic melanoma bearing mice. J. Exp. Ter. Oncol. 2008, 7, 17-29. (Pubitemid 351521214)
27. Guruvayoorappan, C., Kuttan, G. Efect of Biophytum sensitivum on cell-mediated immune response in mice. Immunopharmacol Immunotoxicol. 2007, 29, 337-350. (Pubitemid 350261180)
28. Raphael, T.J., Kuttan, G. Efect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. Phytomedicine 2003, 10, 483-489. (Pubitemid 37092670)
29. Manu, K.A., Kuttan, G. Efect of punarnavine, an alkaloid from Boerhaavia difusa, on cell-mediated immune responses and TIMP-1 in B16F-10 metastatic melanoma-bearing mice. Immunopharmacol. Immunotoxicol. 2007, 29, 569-586. (Pubitemid 350261183)
30. Sunila, E.S., Kuttan, G. Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. J. Ethnopharmacol. 2004, 90, 339-346. (Pubitemid 38180485)
31. Mathew, S., Kuttan, G. Immunomodulatory and antitumour activities of Tinospora cordifolia. Fitoterapia 1999, 70, 35-43. (Pubitemid 29230103)
32. Tejass, P., Kuttan, G. Modulation of cell-mediated immune response in B16F-10 melanoma-induced metastatic tumor-bearing C57BL/6 mice by sulforaphane. Immunopharmacol. Immunotoxicol. 2007, 29, 173-186. (Pubitemid 47394504)
33. Sheeja, K., Kuttan, G. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice. Integr. Cancer Ter. 2007, 6, 66-73.
34. Ahmad, A., Menezes, J. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J. 1996, 10, 258-266. (Pubitemid 26079945)
35. Trinchieri, G. Biology of natural killer cells. Adv. Immunol. 1989, 47, 187-376. (Pubitemid 20010960)
36. Whiteside, T.L., Herberman, R.B. Role of human natural killer cells in health and disease. Clin. Diagn. Lab. Immunol. 1994, 1, 125-133. (Pubitemid 2057582)
37. Moore, M. Natural immunity to tumours-theoretical predictions and biological observations. Br. J. Cancer 1985, 52, 147-151. (Pubitemid 15229347)
38. Tateno, K., Minamino, T., Toko, H., Akazawa, H., Shimizu, N., Takeda, S., Kunieda, T., Miyauchi, H., Oyama, T., Matsuura, K. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ. Res. 2006, 98, 1194-1202. (Pubitemid 43948106)
39. Tricot, G.J. New insights into role of microenvironment in multiple myeloma. Int. J. Hematol. 2002, 76 (Suppl 1), 334-336.
40. Takeda, K., Hatakeyama, K., Tsuchiya, Y., Rikiishi, H., Kumagai, K. A correlation between GM-CSF gene expression and metastases in murine tumors. Int. J. Cancer 1991, 47, 413-420.
41. Ognibene, F.P., Rosenberg, S.A., Lotze, M., Skibber, J., Parker, M.M., Shelhamer, J.H., Parrillo, J.E. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. Chest 1988, 94, 750-754.
42. Rosenberg, S.A., Yang, J.C., Topalian, S.L., Schwartzentruber, D.J., Weber, J.S., Parkinson, D.R., Seipp, C.A., Einhorn, J.H., White, D.E. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 1994, 271, 907-913.
43. Djeu, J.Y., Heinbaugh, J.A., Holden, H.T., Herberman, R.B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J. Immunol. 1979, 122, 175-181. (Pubitemid 9078537)